価格表

在庫・価格 : 2025年04月26日 18時06分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Calnexin, Rabbit-Poly
データシート
NB100-1965 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥96,000
(未発注)
追加

在庫・価格 : 2025年04月26日 18時06分 現在

Anti-Calnexin, Rabbit-Poly

  • 商品コード:NB100-1965
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Tian E et al. O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components. Nat Commun 2012;3:869
Tian E et al
2012/01/01
Applications: IF, Species: Mouse PubMed
2 Saeki T et al. Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107-Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression. BMC Phy
Saeki T et al
2013/01/01
Species: Porcine, Applications: WB PubMed
3 Yuen MY et al. Characterization of Ca(2+) signaling in the external yolk syncytial layer during the late blastula and early gastrula periods of zebrafish development. Biochim. Biophys. Acta 2012 Nov;
Yuen MY et al
2012/01/01
Species: Zebrafish, Applications: IHC, ICC/IF PubMed
4 Riemersma M et al. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid. Hum. Mol. Genet. 2015 Apr;24(8):2241-6
Riemersma M et al
2015/01/01
Species: Human, Applications: WB PubMed
5 Li N et al. Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. Am. J. Hum. Genet. 2016 Jun;98(6):1082-91
Li N et al
2016/01/01
PubMed
6 Xu Y et al. Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 2016 Oct;64(4):1072-85
Xu Y et al
2016/01/01
PubMed
7 McFarlane MR et al. Scap is required for sterol synthesis and crypt growth in intestinal mucosa. J. Lipid Res. 2015 Aug;56(8):1560-71
McFarlane MR et al
2015/01/01
PubMed
8 Smagris E et al. Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins. J. Biol. Chem. 2016 May;291(20):10659-76
Smagris E et al
2016/01/01
PubMed
9 Qi X et al. Two Patched molecules engage distinct sites on Hedgehog yielding a signaling-competent complex. Science 2018 10;362(6410)
Qi X et al
2018/01/01
Species: Human, Applications: WB PubMed
10 Qi X et al. Structures of human Patched and its complex with native palmitoylated sonic hedgehog. Nature 2018 08;560(7716):128-132
Qi X et al
2018/01/01
Species: Human, Applications: WB PubMed
11 Huynh N et al. Characterization of Regulatory Extracellular Vesicles from Osteoclasts. J. Dent. Res. 2016 06;95(6):673-9
Huynh N et al
2016/01/01
PubMed
12 Imperatore R et al. Immunohistochemical Analysis of Intestinal and Central Nervous System Morphology in an Obese Animal Model (<i>Danio rerio</i>) Treated with 3,5-T2: A Possible Farm Management Practice? Animals (Basel) 2020 Jul;10(7)
Imperatore R et al
2020/01/01
PubMed
13 Musante L et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci Rep 2020 02;10(1):3701
Musante L et al
2020/01/01
PubMed
14 Xu Y et al. Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice. Hepatol Commun 2020 Apr;4(4):527-539
Xu Y et al
2020/01/01
PubMed
15 Khalaj K et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight 2019 09;4(18)
Khalaj K et al
2019/01/01
PubMed
16 Jo Y et al. Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with <i>Ubiad1</i> deficiency. Elife 2020 03;9
Jo Y et al
2020/01/01
PubMed
17 Xu Y et al. Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther 2020 01;28(1):202-216
Xu Y et al
2020/01/01
PubMed
18 Millan C et al. Extracellular Vesicles from 3D Engineered Microtissues Harbor Disease-Related Cargo Absent in EVs from 2D Cultures. Adv Healthc Mater 2021 Apr;:e2002067
Millan C et al
2021/01/01
PubMed
19 Xu Y et al. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Mol Metab 2021 Sep;51:101244
Xu Y et al
2021/01/01
PubMed
20 Qi X et al. Sterols in an intramolecular channel of Smoothened mediate Hedgehog signaling. Nat Chem Biol 2020 12;16(12):1368-1375
Qi X et al
2020/01/01
PubMed
21 Xu Y et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 2021 01;3(1):59-74
Xu Y et al
2021/01/01
PubMed
22 Xu Y et al. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4&#x3B1;. Diabetes 2021 Nov;70(11):2506-2517
Xu Y et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Tian E et al. O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components. Nat Commun 2012;3:869
    Tian E et al
    2012/01/01
  • 備考:
    Applications: IF, Species: Mouse
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Saeki T et al. Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107-Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression. BMC Phy
    Saeki T et al
    2013/01/01
  • 備考:
    Species: Porcine, Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Yuen MY et al. Characterization of Ca(2+) signaling in the external yolk syncytial layer during the late blastula and early gastrula periods of zebrafish development. Biochim. Biophys. Acta 2012 Nov;
    Yuen MY et al
    2012/01/01
  • 備考:
    Species: Zebrafish, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Riemersma M et al. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal &#x3B1;-dystroglycan O-mannosylation, independent from sialic acid. Hum. Mol. Genet. 2015 Apr;24(8):2241-6
    Riemersma M et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Li N et al. Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. Am. J. Hum. Genet. 2016 Jun;98(6):1082-91
    Li N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Xu Y et al. Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 2016 Oct;64(4):1072-85
    Xu Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    McFarlane MR et al. Scap is required for sterol synthesis and crypt growth in intestinal mucosa. J. Lipid Res. 2015 Aug;56(8):1560-71
    McFarlane MR et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Smagris E et al. Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins. J. Biol. Chem. 2016 May;291(20):10659-76
    Smagris E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Qi X et al. Two Patched molecules engage distinct sites on Hedgehog yielding a signaling-competent complex. Science 2018 10;362(6410)
    Qi X et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Qi X et al. Structures of human Patched and its complex with native palmitoylated sonic hedgehog. Nature 2018 08;560(7716):128-132
    Qi X et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Huynh N et al. Characterization of Regulatory Extracellular Vesicles from Osteoclasts. J. Dent. Res. 2016 06;95(6):673-9
    Huynh N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Imperatore R et al. Immunohistochemical Analysis of Intestinal and Central Nervous System Morphology in an Obese Animal Model (<i>Danio rerio</i>) Treated with 3,5-T2: A Possible Farm Management Practice? Animals (Basel) 2020 Jul;10(7)
    Imperatore R et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Musante L et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci Rep 2020 02;10(1):3701
    Musante L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Xu Y et al. Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice. Hepatol Commun 2020 Apr;4(4):527-539
    Xu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Khalaj K et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight 2019 09;4(18)
    Khalaj K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Jo Y et al. Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with <i>Ubiad1</i> deficiency. Elife 2020 03;9
    Jo Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Xu Y et al. Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther 2020 01;28(1):202-216
    Xu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Millan C et al. Extracellular Vesicles from 3D Engineered Microtissues Harbor Disease-Related Cargo Absent in EVs from 2D Cultures. Adv Healthc Mater 2021 Apr;:e2002067
    Millan C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Xu Y et al. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Mol Metab 2021 Sep;51:101244
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Qi X et al. Sterols in an intramolecular channel of Smoothened mediate Hedgehog signaling. Nat Chem Biol 2020 12;16(12):1368-1375
    Qi X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Xu Y et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 2021 01;3(1):59-74
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Xu Y et al. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4&#x3B1;. Diabetes 2021 Nov;70(11):2506-2517
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed